Embolotherapy Market by Product (Embolic Agents (Microspheres, Liquid Embolic Agents, Coil), Microcatheters), Indication (Oncology, Vascular, Aneurysm, Urology, Nephrology), Procedure (TACE, TARE), Enduser (Hospital, Clinics, ASC) - Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

The global Embolotherapy market gathered revenue around USD 2.1 Billion in 2020 and market is set to grow USD 7.0 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 9.0% during the prediction period 2021 to 2027.

Embolotherapy Market Size 2020 to 2027

Growth Factors:

The market Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growth over the forecast period. The applications of embolotherapy continue to expand. Initially, embolotherapy was applied for uncontrolled gastrointestinal bleeding; in recent years, embolotherapy is being increasingly adopted for various indications such as non-operative management of solid tumors of the liver, spleen, and kidney; visceral and solid organ aneurysm; vascular malformations in the central nervous systems, pulmonary circulation, head & neck, trunk, and extremities; uterine fibroids; and benign prostatic tumors.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Embolotherapy market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Embolotherapy  market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

Report Scope Details
Market Size USD 7.0 Billion by 2027
Growth Rate CAGR of 9.0% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Product, Application, Procedure, End User, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Boston Medical Corporation , Terumo Medical Systems , Medtronic , Johnson & Johnson , and Stryker Corporation, Sirtex Medical Limited , Abbott Laboratories , Acandis GmbH , Balt , Cook Medical , Kaneka Corporation , Penumbra, Inc. , Merit Medical Systems , Meril Life Sciences Pvt. Ltd. , Cardiva  among others.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Embolotherapy  market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

The Asia Pacific market is expected to grow at the highest CAGR during the forecast period

The embolotherapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Improving healthcare infrastructure in the region, the large patient population for target diseases, and expanding presence of key market players in the region to grab elevating opportunities offered by these countries are the key factors supporting the market growth in this region.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Embolotherapy  Market are:  Boston Medical Corporation , Terumo Medical Systems , Medtronic , Johnson & Johnson , and Stryker Corporation, Sirtex Medical Limited , Abbott Laboratories , Acandis GmbH , Balt , Cook Medical , Kaneka Corporation , Penumbra, Inc. , Merit Medical Systems , Meril Life Sciences Pvt. Ltd. , Cardiva  among others.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Global Embolotherapy market, by Product

  • Embolization Coil
    • Detachable Coils
    • Pushable Coils
  • Embolic Agents
    • Liquid Embolic Agents
    • Microspheres
  • Detachable Balloons
  • Embolic Plug Systems
  • Support Devices
    • Guidewires
    • Microcatheters

Global Embolotherapy market, by Application

  • Oncology
    • Liver Cancer
    • Kidney Cancer
    • Lung Cancer
    • Breast Cancer
    • Other Cancers
  • Peripheral Vascular Diseases
  • Urology and Nephrology
    • Benign Prostatic Hyperplasia
    • Uterine Fibroids
    • Other Urology and Nephrology Applications
  • Neurology
    • Brain Aneurysm
    • Cerebral Arteriovenous Malformations
  • GIT Disorders

Global Embolotherapy market, by Procedure

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

Global Embolotherapy market, by End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Embolotherapy Market, By Product

7.1.  Embolotherapy  Market, by Product, 2020-2027

7.1.1.     Embolization Coil

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Embolic Agents

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Detachable Balloons

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Embolic Plug Systems

7.1.4.1.          Market Revenue and Forecast (2016-2027)

7.1.5.     Support Devices

7.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Embolotherapy Market, By Application

8.1.  Embolotherapy  Market, by Application, 2020-2027

8.1.1.     Oncology

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Peripheral Vascular Diseases

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Urology and Nephrology

8.1.3.1.          Market Revenue and Forecast (2016-2027)

8.1.4.     Neurology

8.1.4.1.          Market Revenue and Forecast (2016-2027)

8.1.5.     GIT Disorders

8.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Embolotherapy Market, By Procedure

9.1.  Embolotherapy  Market, by Procedure, 2020-2027

9.1.1.     Transcatheter Arterial Embolization

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Transarterial Chemoembolization

9.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Embolotherapy Market, By End User

10.1.          Embolotherapy  Market, by End User, 2020-2027

10.1.1.  Hospitals and Clinics

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  Ambulatory Surgical Centers

10.1.2.1.       Market Revenue and Forecast (2016-2027)

10.1.3.  Other End Users

10.1.3.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global Embolotherapy  Market, Regional Estimates and Trend Forecast

11.1.          North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2027)

11.1.2.  Market Revenue and Forecast, by Application (2016-2027)

11.1.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.1.4.  Market Revenue and Forecast, by End User (2016-2027)

11.1.5.  U.S.

11.1.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.1.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.1.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.1.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.1.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.1.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.1.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.          Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2027)

11.2.2.  Market Revenue and Forecast, by Application (2016-2027)

11.2.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.2.4.  Market Revenue and Forecast, by End User (2016-2027)

11.2.5.  UK

11.2.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.2.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.2.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.6.  Germany

11.2.6.1.       Market Revenue and Forecast, by Product(2016-2027)

11.2.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.2.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.2.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.7.  France

11.2.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.7.2.       Market Revenue and Forecast, by Application (2016-2027)

11.2.7.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.2.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.8.2.       Market Revenue and Forecast, by Application (2016-2027)

11.2.8.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.2.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.          APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2027)

11.3.2.  Market Revenue and Forecast, by Application (2016-2027)

11.3.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.3.4.  Market Revenue and Forecast, by End User (2016-2027)

11.3.5.  India

11.3.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.3.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.3.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.6.  China

11.3.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.3.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.3.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.7.  Japan

11.3.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.7.2.       Market Revenue and Forecast, by Application (2016-2027)

11.3.7.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.3.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.8.2.       Market Revenue and Forecast, by Application (2016-2027)

11.3.8.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.3.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.          MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2027)

11.4.2.  Market Revenue and Forecast, by Application (2016-2027)

11.4.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.4.4.  Market Revenue and Forecast, by End User (2016-2027)

11.4.5.  GCC

11.4.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.4.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.4.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.6.  North Africa

11.4.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.4.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.4.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.7.  South Africa

11.4.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.7.2.       Market Revenue and Forecast, by Application (2016-2027)

11.4.7.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.4.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.8.2.       Market Revenue and Forecast, by Application (2016-2027)

11.4.8.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.4.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.5.          Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2027)

11.5.2.  Market Revenue and Forecast, by Application (2016-2027)

11.5.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.5.4.  Market Revenue and Forecast, by End User (2016-2027)

11.5.5.  Brazil

11.5.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.5.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.5.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.5.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.5.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.5.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.5.6.4.       Market Revenue and Forecast, by End User (2016-2027)

Chapter 12.   Company Profiles

12.1.                 Boston Medical Corporation (US)

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.                 Terumo Medical Systems (Japan)

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.                 Medtronic (US)

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.                 Medtronic (US)

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.                 Stryker Corporation (US)

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.                 Sirtex Medical Limited (US)

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.                 Abbott Laboratories (US)

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.                 Acandis GmbH (Germany)

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.                 Acandis GmbH (Germany)

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.              Shape Memory Medical Inc. (US)

12.10.1.                   Company Overview

12.10.2.                   Product Offerings

12.10.3.                   Financial Performance

12.10.4.                   Recent Initiatives

12.11.              Kaneka Corporation (Japan)

12.11.1.                   Company Overview

12.11.2.                   Product Offerings

12.11.3.                   Financial Performance

12.11.4.                   Recent Initiatives

Chapter 13.   Research Methodology

13.1.                 Primary Research

13.2.                 Secondary Research

13.3.                 Assumptions

Chapter 14.   Appendix

14.1.                 About Us

14.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert